Recognizing the increasing need to identify treatments for alcohol use disorder (AUD), researchers from the Imperial College, London, plan to start clinical trials to study the role of 3,4-methylenedioxy-methamphetamine, also known as MDMA, Molly or ecstasy in AUD treatment. The trial is based on the hypothesis that a few doses of the drug, along with counselling and psychotherapy sessions, can help patients recover from alcohol addiction more successfully than conformist treatment programs. The trial was granted ethical approval and is all set to begin by June 2018.
Alcoholism, including abuse, dependence and addiction to alcohol, is one of the most common substance use disorder (SUD) a person is afflicted with in America. Currently, it is estimated that AUDs affect more than 15 million people in the country. The symptoms of alcoholism could range from an unending quest for alcohol to feelings of hopelessness and anxiety, in the absence of it.
Constituent of street version of MDMA not clear
During the course of the trial, 20 volunteers with a heavy drinking habit will attend eight therapy sessions. In two of these sessions, they would be administered MDMA. This is the first-of-its-kind study, where a drug will be tested as a means for providing alcohol addiction support. Nowhere in the world before has the drug been tested for mitigating alcohol abuse. However in the past, the FDA had approved the testing of MDMA for a mental disorder, post-traumatic stress disorder (PTSD), which the researchers suggested was related because both were consequences of anxiety and depression.
There is no knowing what the street version of MDMA contains, and the strength of the constituent chemicals is also unknown. As it is common with most drugs on the street, it is also highly likely that Molly, popular with the kids and seasoned addicts alike, is laced with other drugs. MDMA is pure unadulterated 3,4-methylenedioxy-methamphetamine, a chemical, whose impact can be felt by the user within 45 minutes of ingestion. The peak could last from anywhere between 15 minutes to half an hour. During the high, the user feels highly energized, inexplicably happy and experiences a distorted sense of time and reality. However, it is not for this reason that the researchers are considering administering the drug to people with an AUD.
According to a consultant child psychiatrist Dr. Ben Sessa, a senior research fellow at the Imperial College London, the U.K., the sole reason the drug is on trial for alcohol abuse is because it has the ability to break down many of the fear barriers a person with an AUD could experience during therapy.
Relief from alcoholism possible through timely treatment
What often begins as an innocent and often fun-related social activity for unwinding after the day’s work, alcohol use can soon develop into a full-blown AUD, a complex mental disorder, ruining not only the health of the afflicted, but also his/her personal relationships and reputation in the society.
A leading substance abuse treatment provider in the U.S., Sovereign Health offers cutting-edge treatment options and top notch care for SUDs in a safe, compassionate and trigger-free environment. Alcohol abuse treatment at our state-of-the-art facilities usually includes detox followed by therapy or counseling sessions by trained medical health professionals. To learn more about our recovery programs or to locate our finest alcohol abuse rehab center, call our 24/7 helpline number and speak to our admissions counselor. You can even chat online with our representatives for further assistance.
Get the latest news on program developments, behavioral health news and company announcements